Sample size and power calculation for testing treatment effect heterogeneity in cluster randomized crossover designs
Statistical Methods in Medical Research · 2024
DOI: 10.1177/09622802241247736 ↗Kurz gefasst
Fachartikel in der Zeitschrift Statistical Methods in Medical Research, 2024. Verfasst von Xueqi Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA. Hauptthemen laut MEDLINE: Cross-Over Studies, Randomized Controlled Trials as Topic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NCATS NIH HHS, Patient-Centered Outcomes Research Institute.
Abstract (Originalsprache)
The cluster randomized crossover design has been proposed to improve efficiency over the traditional parallel-arm cluster randomized design. While statistical methods have been developed for designing cluster randomized crossover trials, they have exclusively focused on testing the overall average treatment effect, with little attention to differential treatment effects across subpopulations. Recently, interest has grown in understanding whether treatment effects may vary across pre-specified patient subpopulations, such as those defined by demographic or clinical characteristics. In this article, we consider the two-treatment two-period cluster randomized crossover design under either a cross-sectional or closed-cohort sampling scheme, where it is of interest to detect the heterogeneity of treatment effect via an interaction test. Assuming a patterned correlation structure for both the covariate and the outcome, we derive new sample size formulas for testing the heterogeneity of treatment effect with continuous outcomes based on linear mixed models. Our formulas also address unequal cluster sizes and therefore allow us to analytically assess the impact of unequal cluster sizes on the power of the interaction test in cluster randomized crossover designs. We conduct simulations to confirm the accuracy of the proposed methods, and illustrate their application in two real cluster randomized crossover trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
- Department of Biostatistics, Yale School of Public Health, New Haven, CT, USA.
- Department of Mathematics and Statistics, Mississippi State University, Mississippi State, MS, USA.
- Division of Biostatistics, Department of Population Health, NYU Grossman School of Medicine, New York, NY, USA.
- Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.
- School of Epidemiology and Public Health, University of Ottawa, Ottawa, ON, Canada.
ORCID-Profile: Xueqi Wang, Xinyuan Chen, Fan Li
Förderung
- NIA NIH HHS
- NCATS NIH HHS
- Patient-Centered Outcomes Research Institute
- National Institutes of Health
Zitieren
APA
Wang, X., Chen, X., Goldfeld, K. S., Taljaard, M., & Li, F. (2024). Sample size and power calculation for testing treatment effect heterogeneity in cluster randomized crossover designs. Statistical Methods in Medical Research. https://doi.org/10.1177/09622802241247736
Vancouver
Wang X, Chen X, Goldfeld KS, Taljaard M, Li F. Sample size and power calculation for testing treatment effect heterogeneity in cluster randomized crossover designs. Statistical Methods in Medical Research. 2024. doi:10.1177/09622802241247736
BibTeX
@article{Wang2024,
author = {Wang, Xueqi and Chen, Xinyuan and Goldfeld, Keith S and Taljaard, Monica and Li, Fan},
title = {Sample size and power calculation for testing treatment effect heterogeneity in cluster randomized crossover designs},
journal = {Statistical Methods in Medical Research},
year = {2024},
doi = {10.1177/09622802241247736}
}
EUVIMED